INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 09, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 300 | -- | 556 |
| Sep 30, 2008 |
SVP, Research & Devel Sciences
Trans History: 660
|
SVP, Research & Devel Sciences | Form 4 | Open market or private sale of non-derivative or derivative security | 3,053 | $21.50 | 550 |
| Jul 22, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Other acquisition or disposition | -- | -- | 509 |
| Jun 17, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Other acquisition or disposition | -- | -- | 509 |
| Apr 03, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Other acquisition or disposition | -- | -- | 509 |
| Jan 27, 2020 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Other acquisition or disposition | -- | -- | 509 |
| Dec 23, 2019 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Other acquisition or disposition | -- | -- | 509 |
| Dec 13, 2019 |
VP Controller
Trans History: 306
|
VP Controller | Form 4 | Other acquisition or disposition | -- | -- | 509 |
| Jan 02, 2024 |
Director
Trans History: 4
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 508 | -- | 508 |
| Jan 02, 2024 |
Director
Trans History: 4
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 508 | -- | 508 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.